US President Trump’s sabre-rattling over Greenland kept markets tentative.
The company makes first sale of its pancreatic treatment device in NZ.
George Kerr has a new substantial shareholder to deal with.
Supreme Court judgment has caused serious concern among directors.
Surpassing $265m earnings forecast could mean dividends resume earlier than first thought.
Annual meeting hears of company’s excitement over drilling at Ironbark prospect.
Annual reports show Forsyth Barr had client investments worth $340k with the funds.
The NZX-listed pharmaceutical company has signed a new supply agreement.
Live updates: We follow events and ask the experts throughout the afternoon as results roll in.
Fuel retailer reinstates full-year guidance as half-year bottom line drops a whopping 307%.
